Designing Heart Performance by Gene Transfer
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
The birth of molecular cardiology can be traced to the development and implementation of high-fidelity genetic approaches for manipulating the heart. Recombinant viral vector-based technology offers a highly effective approach to genetically engineer cardiac muscle in vitro and in vivo. This review highlights discoveries made in cardiac muscle physiology through the use of targeted viral-mediated genetic modification. Here the history of cardiac gene transfer technology and the strengths and limitations of viral and nonviral vectors for gene delivery are reviewed. A comprehensive account is given of the application of gene transfer technology for studying key cardiac muscle targets including Ca 2+handling, the sarcomere, the cytoskeleton, and signaling molecules and their posttranslational modifications. The primary objective of this review is to provide a thorough analysis of gene transfer studies for understanding cardiac physiology in health and disease. By comparing results obtained from gene transfer with those obtained from transgenesis and biophysical and biochemical methodologies, this review provides a global view of cardiac structure-function with an eye towards future areas of research. The data presented here serve as a basis for discovery of new therapeutic targets for remediation of acquired and inherited cardiac diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Direct Gene Transfer into Mouse Muscle in Vivo
Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173 · cited 2×
“Despite attempts with a variety of administration techniques, pDNA vectors have very low cardiac transduction efficiency compared with their viral counterparts (975).”
BackgroundA serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyre, E., Radford, I., Villeval, J.-L., Fraser, C. C., Cavazzana-Calvo, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejm200301163480314 · Cited by 1,867 · cited 1×
“Integrating vectors, aside from AAV, have occasionally caused human disease through insertional mutagenesis (309, 310, 800).”
BackgroundMolecular diversity of myofibrillar proteins: gene regulation and functional significance
Schiaffino, S., & Reggiani, C. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.2.371 · Cited by 1,545
Dystrophin protects the sarcolemma from stresses developed during muscle contraction
Petrof, B. J., Shrager, J. B., Stedman, H. H., Kelly, A. M., & Sweeney, H. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3710 · Cited by 1,526
The Way Things Move: Looking Under the Hood of Molecular Motor Proteins
Vale, R. D., & Milligan, R. A. (2000) · Science · doi:10.1126/science.288.5463.88 · Cited by 1,503
Xiao, X., Li, J., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2224-2232.1998 · Cited by 1,381 · cited 1×
“Current protocols now employ a helper-free plasmid cotransfection system to avoid an Ad contamination (299, 300, 983).”
MethodPhospholamban: a crucial regulator of cardiac contractility
MacLennan, D. H., & Kranias, E. G. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1151 · Cited by 1,088
AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B
Manno, C. S., Chew, A. J., Hutchison, S., Larson, P. J., Herzog, R. W., Arruda, V. R., Tai, S. J., Ragni, M. V., Thompson, A., Ozelo, M., et al. (2003) · Blood · doi:10.1182/blood-2002-10-3296 · Cited by 749
Cd8(+) T-Cell Responses to Adeno-Associated Virus Capsid in Humans
Mingozzi, F., Maus, M. V., Hui, D. J., Sabatino, D. E., Murphy, S. L., Rasko, J. E. J., Ragni, M. V., Manno, C. S., Sommer, J., Jiang, H., et al. (2007) · Nature Medicine · doi:10.1038/nm1549 · Cited by 748 · cited 1×
“Early work suggested that AAV vectors may be able to circumvent an immune reaction, but recent studies have now demonstrated that AAV vectors can elicit both a humoral and cellular immune response in a variety of animal models (116, 294, 432, 522, 579, 604).”
BackgroundBurger, C., Gorbatyuk, O. S., Velardo, M. J., Peden, C. S., Williams, P., Zolotukhin, S., Reier, P. J., Mandel, R. J., & Muzyczka, N. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.05.024 · Cited by 741
Nucleotide sequence and organization of the adeno-associated virus 2 genome
Srivastava, A., Lusby, E. W., & Berns, K. I. (1983) · Journal of Virology · doi:10.1128/jvi.45.2.555-564.1983 · Cited by 721
Immune responses to adenovirus and adeno-associated virus in humans
Chirmule, N., Propert, K. J., Magosin, S. A., Qian, Y., Qian, R., & Wilson, J. M. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300994 · Cited by 684 · cited 2×
“Early work suggested that AAV vectors may be able to circumvent an immune reaction, but recent studies have now demonstrated that AAV vectors can elicit both a humoral and cellular immune response in a variety of animal models (116, 294, 432, 522, 579, 604).”
BackgroundVery mild muscular dystrophy associated with the deletion of 46% of dystrophin
England, S. B., Nicholson, L. V. B., Johnson, M. A., Forrest, S. M., Love, D. R., Zubrzycka-Gaarn, E. E., Bulman, D. E., Harris, J. B., & Davies, K. E. (1990) · Nature · doi:10.1038/343180a0 · Cited by 623 · cited 1×
“Significantly truncated dystrophin molecules that retain functionality were first described in patients with Becker muscular dystrophy (212), and additional studies mapped the critical domains required for dystrophin function (144, 329, 687, 718, 777).”
BackgroundSystemic delivery of genes to striated muscles using adeno-associated viral vectors
Gregorevic, P., Blankinship, M. J., Allen, J. M., Crawford, R. W., Meuse, L., Miller, D. G., Russell, D. W., & Chamberlain, J. S. (2004) · Nature Medicine · doi:10.1038/nm1085 · Cited by 620 · cited 9×
“Depending on the exact capsid serotype and delivery method, AAV vectors have transduced nearly 100% of cardiac tissues (294, 893).”
BackgroundInfluentialSelf-citationInagaki, K., Fuess, S., Storm, T. A., Gibson, G. A., Mctiernan, C. F., Kay, M. A., & Nakai, H. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.014 · Cited by 610
Gene therapy vectors based on adeno-associated virus type 1
Xiao, W., Chirmule, N., Berta, S. C., McCullough, B., Gao, G., & Wilson, J. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3994-4003.1999 · Cited by 541
Alterations of Sarcoplasmic Reticulum Proteins in Failing Human Dilated Cardiomyopathy
Meyer, M., Schillinger, W., Pieske, B., Holubarsch, C., Heilmann, C., Posival, H., Kuwajima, G., Mikoshiba, K., Just, H., & Hasenfuss, G. (1995) · Circulation · doi:10.1161/01.cir.92.4.778 · Cited by 535
Davidson, B. L., Stein, C. S., Heth, J. A., Martins, I., Kotin, R. M., Derksen, T. A., Zabner, J., Ghodsi, A., & Chiorini, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3428 · Cited by 531
del Monte, F., Harding, S. E., Schmidt, U., Matsui, T., Kang, Z. B., Dec, G. W., Gwathmey, J. K., Rosenzweig, A., & Hajjar, R. J. (1999) · Circulation · doi:10.1161/01.cir.100.23.2308 · Cited by 502
Cellular basis of abnormal calcium transients of failing human ventricular myocytes
Piacentino, V., Weber, C. R., Chen, X., Weisser-Thomas, J., Margulies, K. B., Bers, D. M., & Houser, S. R. (2003) · Circulation Research · doi:10.1161/01.res.0000062469.83985.9b · Cited by 477
Jooss, K., Yang, Y., Fisher, K. J., & Wilson, J. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.4212-4223.1998 · Cited by 470 · cited 1×
“Adenovirus elicits a potent cellular immune response (416, 991).”
BackgroundDifferential expression of cardiac titin isoforms and modulation of cellular stiffness
Cazorla, O., Freiburg, A., Helmes, M., Centner, T., McNabb, M., Wu, Y., Trombitás, K., Labeit, S., & Granzier, H. (2000) · Circulation Research · doi:10.1161/01.res.86.1.59 · Cited by 418 · cited 1×
“The different titin isoforms confer distinct variations in passive stiffness as demonstrated by the cardiac N2B isoform which elicits higher levels of passive tension per increase in sarcomere length relative to the N2A isoform due to N2B’s shorter extensible region (104, 244, 465, 898).”
BackgroundRecombinant Adeno-Associated Virus Serotype 9 Leads to Preferential Cardiac Transduction In Vivo
Pacak, C. A., Mah, C. S., Thattaliyath, B. D., Conlon, T. J., Lewis, M. A., Cloutier, D. E., Zolotukhin, I., Tarantal, A. F., & Byrne, B. J. (2006) · Circulation Research · doi:10.1161/01.res.0000237661.18885.f6 · Cited by 406
AAV serotype 2 vectors preferentially integrate into active genes in mice
Nakai, H., Montini, E., Fuess, S., Storm, T. A., Grompe, M., & Kay, M. A. (2003) · Nature Genetics · doi:10.1038/ng1179 · Cited by 392
del Monte, F., Williams, E., Lebeche, D., Schmidt, U., Rosenzweig, A., Gwathmey, J. K., Lewandowski, E. D., & Hajjar, R. J. (2001) · Circulation · doi:10.1161/hc3601.095574 · Cited by 382
Chao, H., Liu, Y., Rabinowitz, J., Li, C., Samulski, R. J., & Walsh, C. E. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0219 · Cited by 366
Thomas, C. E., Storm, T. A., Huang, Z., & Kay, M. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.3110-3122.2004 · Cited by 358
New Roles for β-Arrestins in Cell Signaling: Not Just for Seven-Transmembrane Receptors
Lefkowitz, R. J., Rajagopal, K., & Whalen, E. J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.11.007 · Cited by 301 · cited 2×
“Future studies may focus on gene therapy utilizing modified proteins associated with the -AR cycling pathway, such as -arrestin (477) and PDE4 (375, 488), which serve as important proteins in scaffolding and/or desensitization of 2-ARs.”
BackgroundSalva, M. Z., Himeda, C. L., Tai, P. W., Nishiuchi, E., Gregorevic, P., Allen, J. M., Finn, E. E., Nguyen, Q. G., Blankinship, M. J., Meuse, L., et al. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300027 · Cited by 232 · cited 1×
“This technique is capable of transducing other tissues, such as skeletal muscle, although the development of cardiac specific expression cassettes may be able to overcome this possible problem (783).”
BackgroundSelf-citationSchmidt, U., del Monte, F., Miyamoto, M. I., Matsui, T., Gwathmey, J. K., Rosenzweig, A., & Hajjar, R. J. (2000) · Circulation · doi:10.1161/01.cir.101.7.790 · Cited by 230 · cited 4×
“However, when the cardiac circulation is isolated, either during transplantation studies or during heart-lung bypass, global transduction efficiencies of 30–50% can be achieved (83, 84, 187, 188, 801, 845).”
BackgroundMethodInfluentialTransgenic Mouse Model of Stunned Myocardium
Murphy, A. M., Kögler, H., Georgakopoulos, D., McDonough, J. L., Kass, D. A., Van Eyk, J. E., & Marbán, E. (2000) · Science · doi:10.1126/science.287.5452.488 · Cited by 228
Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors
Lai, Y., Yue, Y., Liu, M., Ghosh, A., Engelhardt, J. F., Chamberlain, J. S., & Duan, D. (2005) · Nature Biotechnology · doi:10.1038/nbt1153 · Cited by 224 · cited 2×
“The efficiency of this splicing event, however, appears somewhat less than single vector alone (262, 469).”
BackgroundEndothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury
Jones, S. P., Greer, J. J. M., Kakkar, A. K., Ware, P. D., Turnage, R. H., Hicks, M., van Haperen, R., de Crom, R., Kawashima, S., Yokoyama, M., et al. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00129.2003 · Cited by 206 · cited 1×
“Some of this beneficial effect may be related to NOS3 effects on cardiac-associated neural and endothelial compartments (253, 415, 440, 441, 776).”
BackgroundHeterologous expression of a cardiomyopathic myosin that is defective in its actin interaction
Sweeney, H. L., Straceski, A. J., Leinwand, L. A., Tikunov, B. A., & Faust, L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42067-9 · Cited by 203 · cited 1×
“Since the discovery of this myosin mutation, much effort has been devoted to determining how it affects myosin motor function and triggers cardiomyopathy (60, 146, 147, 671, 856, 905, 987).”
BackgroundWeber, M., Rabinowitz, J., Provost, N., Conrath, H., Folliot, S., Briot, D., Chérel, Y., Chenuaud, P., Samulski, J., Moullier, P., et al. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00098-4 · Cited by 203
Large‐scale molecular characterization of adeno‐associated virus vector integration in mouse liver
Nakai, H., Wu, X., Fuess, S., Storm, T. A., Munroe, D., Montini, E., Burgess, S. M., Grompe, M., & Kay, M. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3606-3614.2005 · Cited by 190
A transgenic rabbit model for human hypertrophic cardiomyopathy
Marian, A. J., Wu, Y., Lim, D.-S., McCluggage, M., Youker, K., Yu, Q.-T., Brugada, R., DeMayo, F., Quinones, M., & Roberts, R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7956 · Cited by 181 · cited 2×
“Additionally, R403Q rabbits had markedly reduced survival rates (526).”
BackgroundCUDA, G., FANANAPAZIR, L., EPSTEIN, N. D., & SELLERS, J. R. (1997) · Journal of Muscle Research & Cell Motility · doi:10.1023/a:1018613907574 · Cited by 137
Lotery, A. J., Yang, G. S., Mullins, R. F., Russell, S. R., Schmidt, M., Stone, E. M., Lindbloom, J. D., Chiorini, J. A., Kotin, R. M., & Davidson, B. L. (2003) · Human Gene Therapy · doi:10.1089/104303403322542301 · Cited by 107
Liu, G., Martins, I. H., Chiorini, J. A., & Davidson, B. L. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302554 · Cited by 84
James, J., Martin, L., Krenz, M., Quatman, C., Jones, F., Klevitsky, R., Gulick, J., & Robbins, J. (2005) · Circulation · doi:10.1161/01.cir.0000164233.09448.b1 · Cited by 77
Transgenic rabbit model for human troponin I-based hypertrophic cardiomyopathy
Sanbe, A., James, J., Tuzcu, V., Nas, S., Martin, L., Gulick, J., Osinska, H., Sakthivel, S., Klevitsky, R., Ginsburg, K. S., et al. (2005) · Circulation · doi:10.1161/01.cir.0000164234.24957.75 · Cited by 74 · cited 3×
“The HCM-linked cTnI mutation R146G increased Ca(2) -activated tension generation in detergent-skinned papillary muscles from the R146G transgenic mice and rabbits (403, 786).”
BackgroundGhosh, A., Yue, Y., & Duan, D. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.835 · Cited by 69
Parvalbumin gene transfer corrects diastolic dysfunction in diseased cardiac myocytes
Wahr, P. A., Michele, D. E., & Metzger, J. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.11982 · Cited by 66
Self-citationSERCA2a in Heart Failure: Role and Therapeutic Prospects
Gianni, D., Chan, J., Gwathmey, J. K., del Monte, F., & Hajjar, R. J. (2005) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-005-9474-z · Cited by 65 · cited 2×
“There are five SERCA isoforms that are encoded by three genes, with SERCA2a being the predominant isoform expressed in the cardiac muscle (263).”
BackgroundOverexpression of γ-Sarcoglycan Induces Severe Muscular Dystrophy
Zhu, X., Hadhazy, M., Groh, M. E., Wheeler, M. T., Wollmann, R., & McNally, E. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101877200 · Cited by 56 · cited 1×
“Interestingly, similar to -SG, overexpression of -SG resulted in significant pathology, presumably secondary to disruption of normal assembly of the sarcoglycan complex (1016).”
BackgroundNakai, H., Montini, E., Fuess, S., Storm, T. A., Meuse, L., Finegold, M., Grompe, M., & Kay, M. A. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(02)00023-0 · Cited by 52
Lateral heterogeneity in the deep mantle from seismic body wave amplitudes
NEEDHAM, R. E., & DAVIES, D. (1973) · Nature · doi:10.1038/244152a0 · Cited by 34
Cited by
Biomechanics of Cardiac Electromechanical Coupling and Mechanoelectric Feedback
Pfeiffer, E. R., Tangney, J. R., Omens, J. H., & McCulloch, A. D. (2014) · Journal of Biomechanical Engineering · doi:10.1115/1.4026221 · Cited by 131
“Though early cardiomyocyte culture work focused on larger and more robust rat cardiomyocytes, transgenic mouse models of human arrhythmia phenotypes have motivated a shift to murine cell culture [121,122].”
BackgroundComparison of adeno-associated virus serotypes and delivery methods for cardiac gene transfer
Fang, H., Lai, N. C., Gao, M. H., Miyanohara, A., Roth, D. M., Tang, T., & Hammond, H. K. (2012) · Human Gene Therapy Methods · doi:10.1089/hgtb.2012.105 · Cited by 58
“mediated gene transfer efficiency and perhaps that of AAV vectors (Davis et al., 2008).”
Soller, K. J., Verardi, R., Jing, M., Abrol, N., Yang, J., Walsh, N., Vostrikov, V. V., Robia, S. L., Bowser, M. T., & Veglia, G. (2015) · Scientific Reports · doi:10.1038/srep13000 · Cited by 12
Metadata
- Authors
- Davis, J., Westfall, M. V., Townsend, D., Blankinship, M., Herron, T. J., Guerrero-Serna, G., Wang, W., Devaney, E., & Metzger, J. M.
- Venue
- Physiological Reviews
- Publisher
- American Physiological Society
- Published
- 2008-10
- Volume
- 88
- Issue
- 4
- Pages
- 1567-1651
- ISSN
- 0031-9333 (ISSN-L)
- 1522-1210
- OpenAlex
- W2171517780
- Cited by
- 59
- References
- 49
- FWCI
- 0.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.